Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2005
09/21/2005EP1576144A2 Proteorhodopsin mutants with improved optical characteristics
09/21/2005EP1576138A2 2-branched nucleosides and flaviviridae mutation
09/21/2005EP1576136A2 Methods for identifying antimicrobial compounds
09/21/2005EP1576134A2 Method for discovering neurogenic agents
09/21/2005EP1576131A2 Brain endothelial cell expression patterns
09/21/2005EP1576126A2 Systems for capture and analysis of biological particles and methods using the systems
09/21/2005EP1576119A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
09/21/2005EP1576111A2 Cancer-linked gene as target for chemotherapy
09/21/2005EP1576109A2 Methods and compositions for categorizing patients
09/21/2005EP1576108A2 Nitrilases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576106A2 Process and materials for production of glucosamine and n-acetylglucosamine
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576098A2 A human cell assay to determine effect of sample compounds on col2 enhancer expression
09/21/2005EP1576096A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
09/21/2005EP1576094A2 Methods of creating modified promoters resulting in varying levels of gene expression
09/21/2005EP1576089A2 Expansion of renewable stem cell populations
09/21/2005EP1576087A2 Method for detecting remote homologues and kinases identified with the method
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576042A2 Optical information carrier comprising immobilized proteorhodopsin
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1576007A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
09/21/2005EP1575997A2 Phosphospecific pak antibodies and diagnostic kits
09/21/2005EP1575996A2 Genes involved in neuropsychiatric disorders
09/21/2005EP1575993A2 Methods for treating patients and identifying therapeutics
09/21/2005EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
09/21/2005EP1575990A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis
09/21/2005EP1575986A2 Peptides and methods for cell death regulation
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575978A2 Diagnosis of sepsis or sirs using biomarker profiles
09/21/2005EP1575972A1 Nucleic acid labeling compounds
09/21/2005EP1575917A2 Hemipteran muscarinic receptor
09/21/2005EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
09/21/2005EP1575881A2 Alanine 2,3- aminomutase
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575534A2 D4,5 glycuronidase and uses thereof
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575520A2 A process for preparation of an agglutination reagent for rapid detection of typhoid
09/21/2005EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase
09/21/2005EP1575510A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
09/21/2005EP1575505A2 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575498A2 Antisense modulation of microsomal prostaglandin e2 synthase expression
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575492A2 Cancer-linked gene as target for chemotherapy
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1575485A2 Methods for lightening skin and hair
09/21/2005EP1575481A2 Methods to increase or decrease bone density
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
09/21/2005EP1575420A2 Prostate cancer biomarkers
09/21/2005EP1575417A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
09/21/2005EP1575416A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
09/21/2005EP1430154A4 Enzyme-amplified redox microarray detection process
09/21/2005EP1399588A4 Method and sequences for determinate nucleic acid hybridization
09/21/2005EP1294877B1 Cgi-69 compositions and methods of use
09/21/2005EP1276904A4 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
09/21/2005EP1204740B1 Methods and compositions for directed cloning and subcloning using homologous recombination
09/21/2005EP1194174B1 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
09/21/2005EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1104326B1 Apparatus for the delivery of drugs and genes into tissue
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP1015643B1 Method and reagents for analyzing the nucleotide sequence of nucleic acids
09/21/2005EP0961836B1 Dna encoding canine von willebrand factor and methods of use
09/21/2005EP0894145B1 Drug trial assay system
09/21/2005EP0885310B1 Genetic markers and methods for the detection of escherichia coli serotype-0157:h7
09/21/2005EP0856067A4 A binary coding method for use in combinatorial chemistry
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
09/21/2005EP0752853B1 Human brain phosphodiesterase
09/21/2005CN1672054A Detecting receptor oligomerization
09/21/2005CN1672052A Nano-sized optical fluorescence labels and uses thereof
09/21/2005CN1672050A Fluorescence polarization assay
09/21/2005CN1672046A Method for identifying substances
09/21/2005CN1672040A Method for analyzing probes carrier using time-of-flight secondary ion mass spectrometry with halogen labeling
09/21/2005CN1671866A PTHrP-based prediction and diagnosis of bone disease
09/21/2005CN1671865A Microparticle based signal amplification method and its application in the detection of analytes
09/21/2005CN1671864A Photonic signal reporting of electrochemical events
09/21/2005CN1671862A Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
09/21/2005CN1671860A Functional cardiomyocytes from human embryonic stem cells
09/21/2005CN1671859A Method for identifying individual active entities from complex mixtures
09/21/2005CN1671845A Immunogenic sequences
09/21/2005CN1671841A Method of typing gene polymorphisms
09/21/2005CN1671839A 葡萄糖脱氢酶 Glucose dehydrogenase
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671425A ACE2 activation for treatment of heart, lung and kidney disease and hypertension
09/21/2005CN1671373A Compounds useful for the inhibition of ALDH
09/21/2005CN1670222A Method for detecting mononucleotide polymorphism and point mutation
09/21/2005CN1670221A Primer, probe series and method for multiple real time fluorescent RT-PCR detection of H5, H7 and H9 subtype bird flu
09/21/2005CN1670220A Primer and probe series for real time fluorescent RT-PCR detection of bird flu of H7 subtype
09/21/2005CN1670219A Primer and probe series for real time fluorescent RT-PCR detection of bird flu H9 subtype
09/21/2005CN1670218A Method for screening salt-tolerant medicinal dandelion herb and its special primer
09/21/2005CN1670215A Method for preparing transgenic bombyx mori and its application in pharmacy
09/21/2005CN1670213A Glyt1 transgenic mouse
09/21/2005CN1670206A Protease subunit C7-I of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670205A Protease subunit C3 of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670204A Autolytic enzyme of streptococcus pneumoniae, its coding nucleic acid and application
1 ... 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 ... 3003